GNH USA

Europe — EMA

Menotrophin

GNH USA supplies Menotrophin (Menotrophin), a gonadotropin for ovulation induction, controlled ovarian stimulation and infertility due to anovulation.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotrophin, the active ingredient in Menotrophin, is a gonadotropin presented as a injectable solution for intramuscular, subcutaneous use. It treats infertility due to anovulation and is used in ovulation induction and controlled ovarian stimulation.

GNH USA supplies Menotrophin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menotrophin acts on the reproductive hormone pathway to support follicular development and ovulation. - Ovulation induction: stimulates follicular growth to achieve ovulation in anovulatory patients. - Controlled ovarian stimulation: enhances multiple follicle development for assisted reproductive techniques. - Infertility due to anovulation: improves chances of conception by providing exogenous FSH and LH activity.

What are the side effects of Menotrophin?

Menotrophin may cause a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema. - Mild abdominal discomfort or bloating. - Headache. - Nausea. - Mild ovarian hyperstimulation syndrome.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome with fluid shift and thromboembolic risk. - Multiple pregnancy. - Anaphylactic or severe allergic reactions. - Ectopic pregnancy.

What precautions apply to Menotrophin?

When using Menotrophin, careful monitoring and patient assessment are essential. - Monitor ovarian response: use serial ultrasound to adjust dose. - Assess OHSS risk: avoid high doses in patients with prior severe OHSS. - Contraindicated in pregnancy: do not administer after conception. - Caution with hormone‑sensitive tumors: evaluate risk before therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menotrophin may interact with other medications that affect ovarian response or hemostasis.

Major Interactions (Avoid): - Concurrent use of other gonadotropins: increases risk of severe OHSS. - High‑dose estrogen therapy: may alter follicular dynamics.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor for injection‑site bleeding. - Corticosteroids: may affect hormone metabolism. - Thyroid hormone replacement: adjust dosing based on thyroid status.

Frequently asked questions

What is Menotrophin used for?+
Menotrophin is a gonadotropin indicated for ovulation induction, controlled ovarian stimulation, and treatment of infertility caused by anovulation. It provides exogenous FSH and LH activity to promote follicular development in women undergoing assisted reproductive techniques.
How does Menotrophin work?+
Menotrophin contains both follicle‑stimulating hormone (FSH) and luteinising hormone (LH) analogues. These bind to FSH and LH receptors on ovarian granulosa and theca cells, stimulating follicular growth, estradiol synthesis and final maturation, ultimately leading to ovulation.
What is the usual dose of Menotrophin?+
The prescribed dose of Menotrophin is individualized by the treating physician based on the patient’s ovarian response, age, body weight and the specific assisted reproduction protocol. Dosing regimens are determined after baseline assessment and monitoring.
Is Menotrophin safe during pregnancy or breastfeeding?+
Menotrophin is intended for use before conception to induce ovulation; it is not administered during an established pregnancy. Safety data for use while breastfeeding are limited, and the product should be avoided unless the prescriber determines that benefits outweigh potential risks.
How do I order Menotrophin from GNH USA?+
To place an order, submit an enquiry on the Menotrophin product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.
How does Menotrophin compare with other fertility drugs?+
Compared with recombinant FSH preparations, Menotrophin provides a combination of FSH and LH activity in a single preparation, which can simplify dosing for patients requiring both hormones. Recombinant products are pure FSH and may be preferred when isolated LH activity is not needed. Clinical choice depends on protocol, cost, and patient response.
What are the storage requirements for Menotrophin?+
Menotrophin must be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the solution. If the product reaches room temperature, it should be returned to refrigeration promptly and used within the stability period indicated by the manufacturer.
How is Menotrophin administered?+
Menotrophin is supplied as a sterile injectable solution for intramuscular or subcutaneous injection. The injection is typically performed by a trained healthcare professional or a patient after proper instruction. Injection sites are rotated to minimize local reactions, and dosing is adjusted according to ultrasound monitoring of follicular development.
What are the most serious risks associated with Menotrophin?+
The most serious adverse events include severe ovarian hyperstimulation syndrome (OHSS), which can cause abdominal pain, fluid accumulation, and thromboembolic complications, as well as multiple pregnancy and rare allergic reactions such as anaphylaxis. Prompt medical evaluation is required if any of these symptoms occur.
Who should not use Menotrophin?+
Menotrophin is contraindicated in women with known hypersensitivity to any component of the product, in those with active ovarian cysts, uncontrolled thyroid disease, hormone‑dependent tumors, or in pregnancy. Caution is advised for patients with severe cardiovascular disease or a history of thromboembolic events. The prescribing clinician determines suitability.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring Ireland Ltd.
Origin
EU

Related products